Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder

Journal of Child Neurology

Volumn 15, Issue 2, 2000, Pages 90-96

  Kayl, Anne E ^a   Moore, Bartlett D ^a   Slopis, John M ^b   Jackson, Edward F ^a   Leeds, Norman E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CORPUS CALLOSUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0034054727     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500206     Document Type: Article

References (51)

1. National Institutes of Health Consensus Development Conference: Neurofibromatosis: Conference statement. Arch Neurol 1988;45:575-578.
2. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-1627.
3. Hofman KJ, Harris EL, Bryan N, Denckla M: Neurofibromatosis type 1: The cognitive phenotype. J Pediatr 1994;124:S1-S8.
4. North K, Joy P, Yuille D, et al: Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995;37:427-436.
5. Denckla MB, Hofman K, Mazzocco MMM, et al: Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996;67:98-102.
6. North KN, Riccardi V, Samango-Sprouse C, et al: Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 1997;48:1121-1127.
7. Eliason MJ: Neurofibromatosis: Implications for learning and behavior. J Dev Behav Pediatr 1986;7:175-179.
8. Riccardi VM: The multiple forms of neurofibromatosis. Pediatr Rev 1982;3:293-298.
9. Moore BD, Slopis JM, Schomer MD, et al: Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-1668.
10. Stine S, Adams W: Learning problems in neurofibromatosis patients. Clin Orthop 1989;245:43-48.
11. Yamanouchi H, Kato T, Matsuda H, et al: MRI in neurofibromatosis type 1: Using fluid attenuated inversion recovery pulse sequences. Pediatr Neurol 1995;12:286-290.
12. Duffner P, Cohen M, Seidel G, Shucard D: The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-378.
13. Listernick R, Charrow J, Greenwald MJ, Easterly NB: Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1988;114:788-792.
14. DiMario FJ, Ramsby G: Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 1998;55:500-505.
15. Sherman JL: Imaging, in Mulvihill JJ (moderator): Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis): An update. Ann Intern Med 1990;113:39-52.
16. Moore BD 3rd, Ater JL, Needle MN, et al: Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol 1994;9:368-377.
17. North K, Joy P, Yuille D, et al: Learning difficulties in neurofibromatosis type 1: The significance of MRI abnormalities. Neurology 1994;44:878-883.
18. Lou HC, Henriksen L, Bruhn P, et al: Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1989;46:48-52.
19. Gualtieri CT, Hicks RE: Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity. Psychiatr Clin North Am 1991;14:113-124.
20. Filipek PA, Semrud-Clikeman M, Steingard RJ, et al: Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589-601.
21. Heilman KM, Voeller KK, Nadeau SE: A possible pathophysiologic substrate of attention deficit hyperactivity disorder. J Child Neurol 1991;6(Suppl):S76-S81.
22. Zametkin AJ, Nordahl TE, Gross M, et al: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323:1361-1366.
23. Shaywitz BA, Shaywitz SE, Byrne T, et al: Attention deficit disorder: Quantitative analysis of CT. Neurology 1983;33:1500-1503.
24. Hynd GW, Semrud-Clikeman M, Lorys AR, et al: Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Arch Neurol 1990;47:919-926.
25. Castellanos FX, Giedd JN, Eckburg P, et al: Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:1791-1796.
26. Hynd GW, Hern KL, Novey ES, et al: Attention deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339-347.
27. Hynd GW, Semrud-Clikeman M, Lorys AR, et al: Corpus callosum morphology in attention deficit-hyperactivity disorder: Morphometric analysis of MRI. J Learn Dis 1991;24:141-146.
28. Semrud-Clikeman M, Filipek PA, Biederman J, et al: Attention deficit hyperactivity disorder: Magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 1994;33:875-881.
29. Giedd JN, Castellanos FX, Casey BJ, et al: Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:665-669.
30. Castellanos FX, Giedd JN, Marsh WL, et al: Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996;53:607-616.
31. Baumgardner TL, Singer HS, Denckla MD, et al: Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 1996;47:477-482.
32. Witelson SF: Hand and sex differences in the isthmus and genu of the human corpus callosum. Brain 1989;112:799-835.
33. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.
34. Achenbach TM, Edelbrock CS: Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington, University of Vermont Department of Psychiatry, 1983.
35. Wirt RD, Lachar D, Klinedinst JK, Seat PD: Multidimensional Description of Child Personality. A Manual for the Personality Inventory for Children. Los Angeles, Western Psychological Services, 1990.
36. Achenbach TM, Edelbrock CS: Manual for the Teacher's Report Form and Teacher Version of the Child Behavior Profile. Burlington, University of Vermont Department of Psychiatry, 1986.
37. Hollingshead AB: Two Factor Index of Social Position. New Haven, CT, Yale University Press, 1957.
38. Baron IS, Fennell EB, Voeller KKS: Neurodevelopmental and genetic syndromes, in Pediatric Neuropsychology in the Medical Setting. New York, Oxford University Press, 1995, pp 64-113.
39. Schaefer GB, Thompson JN, Bodensteiner JB, et al: Quantitative morphometric analysis of brain growth using magnetic resonance imaging. J Child Neurol 1990;5:127-130.
40. Pujol J, Vendrell P, Junque C, et al: When does human brain development end? Evidence of corpus callosum growth up to adulthood. Ann Neurol 1993;34:71-75.
41. Schaefer GB, Shuman RM, Wilson DA, et al: Partial agenesis of the anterior corpus callosum: Correlation between appearance, imaging, and neuropathology. Pediatric Neurol 1991;7:39-44.
42. Fletcher JM, Bohan TP, Brandt ME, et al: Cerebral white matter and cognition in hydrocephalic children. Arch Neurol 1992;49: 818-824.
43. Dennis MD: Cerebral dominance in three forms of early brain disorder, in Blaw ME, Rapin I, Kinsbourne M (eds): Topics in Child Neurology, New York, Spectrum, 1977, pp 189-212.
44. Gazzaniga MS: The Bisected Brain. New York, Appleton-Century-Crofts, 1970.
45. Said SM, Yeh TL, Greenwood RS, et al: MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport 1996;7:1941-1944.
46. th Annual NNFF Clinical Care Symposium, San Francisco, 1992.
47. Danglot G, Regnier V, Fauvet D, et al: Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet 1995;4: 915-920.
48. Geist RT, Gutmann DH: Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett 1996;211:85-88.
49. The I, Hannagan GE, Cowley GS, et al: Rescue of a Drosophila NF-1 mutant, phenotype by protein kinase A. Science 1997;276:791-794.
50. Guo H-F, The I, Hannan H, et al: Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997;276:795-798.
51. Gutmann DH: Recent insights into neurofibromatosis type 1. Arch Neurol 1998;55:778-780.